Solara Active Pharma Sciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 24/03/2026 ,inter alia, to consider and approve the second & ....
SOLARA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 1.2 pts less than Nifty Microcap 250 and 1.0 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Solara Active Pharma Sciences has informed the stock exchanges that its Rights Issue Committee will meet on March 24, 2026. The committee will consider making the Second and Final Call on partly paid-up equity shares that were issued to shareholders via a rights issue based on the Letter of Offer dated May 9, 2024. The board will also fix a Record Date to identify which shareholders are liable to pay this remaining call money. This means shareholders who applied for the 2024 rights issue still owe a portion of the share price, and the company is now moving to collect the final instalment.
Eligible shareholders will need to pay the remaining call money by the deadline set after the record date. Failure to pay could result in forfeiture of the partly paid-up shares. The actual cash inflow to the company and impact on share price will depend on the call price and how many shareholders pay on time.